49 Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.87M Buy
1,561
+921
+144% +$941K 0.36% 56
2026
Q1
$589K Buy
640
+71
+12% +$72K 0.04% 102
2025
Q4
$611K Buy
569
+84
+17% +$80.3K 0.05% 94
2025
Q3
$370K Buy
485
+62
+15% +$46.1K 0.03% 126
2025
Q2
$330K Sell
423
-84
-17% -$65.3K 0.04% 127
2025
Q1
$419K Sell
507
-251
-33% -$209K 0.05% 105
2024
Q4
$585K Buy
758
+319
+73% +$264K 0.08% 75
2024
Q3
$389K Sell
439
-9
-2% -$8.09K 0.06% 99
2024
Q2
$409K Buy
448
+121
+37% +$96.8K 0.08% 92
2024
Q1
$249K Buy
+327
New +$233K 0.05% 101

Other funds holding LLY

49 Wealth Management's LLY Position: Q2 2026 in Review

49 Wealth Management increased its Eli Lilly (LLY) stake by 144% in Q2 2026, buying an estimated $941K and bringing the position to 1,561 shares worth $1.87M. The position accounts for 0.36% of the portfolio, ranked #56.

49 Wealth Management first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • 49 Wealth Management held 1,561 shares of Eli Lilly worth $1.87M as of Q2 2026.
  • 49 Wealth Management bought 921 Eli Lilly shares in Q2 2026, an estimated $941K.
  • Eli Lilly made up 0.36% of 49 Wealth Management's portfolio in Q2 2026, its #56 holding.
  • 49 Wealth Management first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on 49 Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.